$KDNY
Chinook Therapeutics Inc
PRICE
$40.32 ▼-0.173%
Extented Hours
VOLUME
4,924,994
DAY RANGE
40.295 - 40.51
52 WEEK
0 - 40.51
Key Metrics
Market Cap
0
Beta
0
Avg. Volume
0
Shares Outstanding
71.80 M
Yield
0%
Public Float
0
Next Earnings Date
Next Dividend Date
Company Information
chinook therapeutics (nasdaq: kdny) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems. drug development in kidney diseases is experiencing a resurgence due to greater understanding of disease biology, utilization of novel translational platforms and patient stratification tools, and emergence of accelerated regulatory pathways based on surrogate endpoints.
CEO: Stephen Isaacs
Website: http://www.aduro.com/
HQ: 740 Heinz Ave Berkeley, 94710-2748 California
Related News